11.01.2019 - By NEJM Group
Running time: 23 minutes Paula Byrne set out to understand what the available data tell us about how many people are taking statins for primary prevention — and how much good is it likely doing them? Also, how do you discuss their possible harms and benefits with patients? Links: Paula Byrne and colleagues’ analysis in The BMJ Kausik Ray […]